KRIBIOLISA™ Glatiramer Acetate (COPAXONE) ELISA
Immunoassay for quantitative estimation of Glatiramer Acetate in human serum and plasma. Validated for both serum and plasma samples, this Exenatide ELISA gives specific, accurate results with a ready-to-use assay format.
Receive your quote directly from the manufacturer.
With highly specific antibodies, proprietary stabilizers and blockers, and a seven point validation system, this ELISA is accurate, sensitive and easy to use. The Glatiramer Acetate assay is intended to measure these peptide drugs for potency and pharmacokinetic studies with both generics and biosimilar drugs.
Peptide drugs in therapeutics is becoming increasingly popular, as peptides are recognized for being highly selective and efficacious and, at the same time, relatively safe and well tolerated.
About this Glatiramer Acetate assay:
- Uses highly specific antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity
- Recovery rates are 80 - 120%
- Validated as per US FDA guidelines for Bioassays
- Optimized for matrix effects to ensure higher sensitivity
- Uses the innovator drug (COPAXONE) as calibrator, and is optimized for biosimilars and generics
